TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 7, 2012, Pages

  Iwasaki, Hitoshi ^a   Naka, Ayano ^b   Iida, Kaoruko Tada ^b,c   Nakagawa, Yoshimi ^a   Matsuzaka, Takashi ^a   Ishii, Kiyo aki ^a   Kobayashi, Kazuto ^a   Takahashi, Akimitsu ^a   Yatoh, Shigeru ^a   Yahagi, Naoya ^a   Sone, Hirohito ^a   Suzuki, Hiroaki ^a   Yamada, Nobuhiro ^a   Shimano, Hitoshi ^a,b  

^a Faculty of Medicine   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Glucose transporter 4; Glycogen synthase; Hexokinase 2; Skeletal muscles; Transcription factor E3

Indexed keywords

GLUCOSE TRANSPORTER 4; GLYCOGEN; GLYCOGEN SYNTHASE; HEXOKINASE; HEXOKINASE 2; INSULIN RECEPTOR SUBSTRATE 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDURANCE; ENDURANCE TRAINING; FEMALE; GENE CONTROL; GENE EXPRESSION; GLUCOSE METABOLISM; GROWTH ACCELERATION; INSULIN SENSITIVITY; MALE; MOUSE; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION; WILD TYPE;

ADENOVIRIDAE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN SYNTHASE; HEXOKINASE; HUMANS; INSULIN RESISTANCE; LIVER; LIVER GLYCOGEN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; RNA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84859470878     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00204.2011     Document Type: Article

References (28)

1. Aschenbach WG, Suzuki Y, Breeden K, Prats C, Hirshman MF, Dufresne SD, Sakamoto K, Vilardo PG, Steele M, Kim JH, Jing SL, Goodyear LJ, DePaoli-Roach AA. The muscle-specific protein phospha-tase PP1G/R(GL)(G(M)) is essential for activation of glycogen synthase by exercise. J Biol Chem 276: 39959-39967, 2001.
2. Beckmann H, Su LK, Kadesch T. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev 4: 167-179, 1990.
3. Brennan KJ, Hardeman EC. Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. J Biol Chem 268: 719-725, 1993.
4. Chan TM, Exton JH. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepato-cytes. Anal Biochem 71: 96-105, 1976.
5. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341: 240-246, 1999.
6. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
7. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Granner DK, Wasserman DH. Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice. Diabetes 53: 306-314, 2004.
8. Fueger PT, Shearer J, Krueger TM, Posey KA, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. J Physiol 566: 533-541, 2005.
9. Greiwe JS, Hickner RC, Hansen PA, Racette SB, Chen MM, Holloszy JO. Effects of endurance exercise training on muscle glycogen accumulation in humans. J Appl Physiol 87: 222-226, 1999.
10. Holmes BF, Kurth-Kraczek EJ, Winder WW. Chronic activation of 5=-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87: 1990-1995, 1999.
11. Howlett KF, Sakamoto K, Hirshman MF, Aschenbach WG, Dow M, White MF, Goodyear LJ. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice. Diabetes 51: 479-483, 2002.
12. Howlett KF, Sakamoto K, Yu H, Goodyear LJ, Hargreaves M. Insulin-stimulated insulin receptor substrate-2-associated phosphatidyl-inositol 3-kinase activity is enhanced in human skeletal muscle after exercise. Metabolism 55: 1046-1052, 2006.
13. Hua X, Liu X, Ansari DO, Lodish HF. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev 12: 3084-3095, 1998.
14. Ivy JL. Role of carbohydrate in physical activity. Clin Sports Med 18: 469-484, 1999.
15. Iwasaki Y, Iwasaki H, Yatoh S, Ishikawa M, Kato T, Matsuzaka T, Nakagawa Y, Yahagi N, Kobayashi K, Takahashi A, Suzuki H, Yamada N, Shimano H. Nuclear SREBP-1a causes loss of pancreatic beta-cells and impaired insulin secretion. Biochem Biophys Res Commun 378: 545-550, 2009.
16. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105: 199-205, 2000.
17. Klip A, Paquet MR. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13: 228-243, 1990.
18. Kraniou Y, Cameron-Smith D, Misso M, Collier G, Hargreaves M. Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol 88: 794-796, 2000.
19. Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N, Yamada N. TFE3 tran-scriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 12: 107-113, 2006.
20. Nakatani A, Han DH, Hansen PA, Nolte LA, Host HH, Hickner RC, Holloszy JO. Effect of endurance exercise training on muscle glycogen supercompensation in rats. J Appl Physiol 82: 711-715, 1997.
21. O'Doherty RM, Bracy DP, Granner DK, Wasserman DH. Transcription of the rat skeletal muscle hexokinase II gene is increased by acute exercise. J Appl Physiol 81: 789-793, 1996.
22. Pederson BA, Cope CR, Irimia JM, Schroeder JM, Thurberg BL, Depaoli-Roach AA, Roach PJ. Mice with elevated muscle glycogen stores do not have improved exercise performance. Biochem Biophys Res Commun 331: 491-496, 2005.
23. Peng Y, Schwarz EJ, Lazar MA, Genin A, Spinner NB, Taub R. Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene. Genomics 43: 278-284, 1997.
24. Rockl KS, Hirshman MF, Brandauer J, Fujii N, Witters LA, Goodyear LJ. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56: 2062-2069, 2007.
25. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 22: 674-682, 2005.
26. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223-228, 1990.
27. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277: 19353-19357, 2002.
28. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol 16: 3074-3084, 1996.